Table 1.
Presents the sociodemographic and clinic characteristics.
| n | % | |
|---|---|---|
| Age – <65 years – ≥65 years |
24 14 |
(63.2) (36.8) |
| Sex – Women – Men |
17 21 |
(44.7) (55.3) |
| ECOG – 0 – 1 – 2 – 3 |
3 23 10 2 |
(7.9) (60.5) (26.3) (5.3) |
| Smoking status – No – Yes |
24 13 |
(63.2 (34.2) |
| Comorbidity – No – Yes |
26 10 |
(68.4) (26.3) |
| Mutation – EGFR – ALK – ROS – BRAF |
23 12 2 1 |
(60.5) (31.6) (5.3) (2.6) |
| Which series – First line – Second line and after |
19 19 |
(50.0) (50.0) |
| Metastasis site in diagnosis – Lung – Brain – Bone – Surrenal – Multiple |
13 7 12 3 2 |
(34.2) (18.4) (31.6) (7.9) (5.3) |
| Brain metastases on follow-up – No – Yes |
8 29 |
(21.1) (76.3) |
| Progression – No – Yes |
6 32 |
(15.8) (84.2) |
| Latest status – Live – Exitus |
8 30 |
(21.1) (78.9) |
| NLR – <2.57 – ≥2.57 |
13 25 |
(34.2) (65.8) |
| PNI – <37.7 – ≥37.7 |
21 17 |
(55.3) (44.7) |
| SII – <799.5 – ≥799.5 |
14 24 |
(36.8) (63.2) |
| Neutrophil – <5.2 – ≥5.2 |
15 23 |
(39.5) (60.5) |
| Lymphocyte – <2.03 – ≥2.03 |
21 17 |
(55.3) (44.7) |
ECOG: Eastern Cooperative Oncology Group; NLR: Neutrophil–lymphocyte ratio; PNI: Prognostic nutritional index; SII: Systemic immune-inflammation index.